FDA Drug recall D-1569-2014
CHIROTHIN Dietary Supplement, 2 Fl Oz (60 ml), OTC. Manufactured for ChiroNeutraceutical, 877-377-7636, Chesterfield, MO 63005
- FDA Drug
- Class III
- terminated
- Published 2014-09-17
On 2014-09-17 the FDA classified a Class III recall of CHIROTHIN Dietary Supplement, 2 Fl Oz (60 ml), OTC. Manufactured for ChiroNeutraceutical, 877-377-7636, Chesterfield, MO 63005 by Chironutraceutical, citing marketed without an Approved NDA/ANDA; Product contains unapproved hHCG.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1569-2014 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2014-08-20 |
| Published | 2014-09-17 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Chironutraceutical |
| Distribution | US |
Product
CHIROTHIN Dietary Supplement, 2 Fl Oz (60 ml), OTC. Manufactured for ChiroNeutraceutical, 877-377-7636, Chesterfield, MO 63005.
Reason
Marketed without an Approved NDA/ANDA; Product contains unapproved hHCG.
Identifiers
| code_info | Lot #: 072010-22, Exp: 12/2013; Lot #: 072010-23, Exp: 01/2014; Lot #: 072010-25, Exp: 03/2014; Lot #: 072010-26, Ex…Lot #: 072010-22, Exp: 12/2013; Lot #: 072010-23, Exp: 01/2014; Lot #: 072010-25, Exp: 03/2014; Lot #: 072010-26, Exp: 04/2014; Lot #: 072010-27, Exp: 05/2014; Lot #: 072010-29, Exp: 07/2014; Lot #: 072010-30, Exp: 08/2014; Lot #: 072010-31, Exp: 09/2014; Lot #: 072010-33, Exp: 11/2014; Lot #: 072010-34, Exp: 01/2015; Lot #: 072010-36, Exp: 02/2015; Lot #: 072010-39, Exp: 05/2015; Lot #: 072010-43, Exp: 06/2015; and Lot #: 072010-48, Exp: 10/2015. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1569-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.